Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
For the first time in a decade, the American Heart Association and American Stroke Association issued new recommendations for ...
What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...
4hon MSN
Forget Ozempic drug that Karan Johar was accused of taking for dramatic weight loss. Here are 8 expert ways to naturally ...
News Medical on MSN5d
Expanding access to GLP-1 weight-loss drugs could save thousands of livesResearchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...
However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies are pursuing other approaches that could be even more effective or ...
GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback